Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium.

Advances in Medicine Pub Date : 2019-01-02 eCollection Date: 2019-01-01 DOI:10.1155/2019/2675972
Ulrich Gergs, Theresa Trapp, Hasan Bushnaq, Andreas Simm, Rolf-Edgar Silber, Joachim Neumann
{"title":"Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium.","authors":"Ulrich Gergs,&nbsp;Theresa Trapp,&nbsp;Hasan Bushnaq,&nbsp;Andreas Simm,&nbsp;Rolf-Edgar Silber,&nbsp;Joachim Neumann","doi":"10.1155/2019/2675972","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure and aging of the heart show many similarities regarding hemodynamic and biochemical parameters. There is evidence that heart failure in experimental animals and humans is accompanied and possibly exacerbated by increased activity of protein phosphatase (PP) 1 and/or 2A. Here, we wanted to study the age-dependent protein expression of major members of the protein phosphatase family in human hearts. Right atrial samples were obtained during bypass surgery. Patients (<i>n</i>=60) were suffering from chronic coronary artery disease (CCS 2-3; New York Heart Association (NYHA) stage 1-3). Age ranged from 48 to 84 years (median 69). All patients included in the study were given <i>β</i>-adrenoceptor blockers. Other medications included angiotensin-converting enzyme (ACE) or angiotensin-receptor-1 (AT<sub>1</sub>) inhibitors, statins, nitrates, and acetylsalicylic acid (ASS). 100 <i>µ</i>g of right atrial homogenates was used for western blotting. Antibodies against catalytic subunits (and their major regulatory proteins) of all presently known cardiac serine/threonine phosphatases were used for antigen detection. In detail, we studied the expression of the catalytic subunit of PP1 (PP1c); I<sub>1</sub> <sup>PP1</sup> and I<sub>2</sub> <sup>PP1</sup>, proteins that can inhibit the activity of PP1c; the catalytic subunit of PP2A (PP2Ac); regulatory A-subunit of PP2A (PP2A<sub>A</sub>); regulatory B56<i>α</i>-subunit of PP2A (PP2A<sub>B</sub>); I<sub>1</sub> <sup>PP2A</sup> and I<sub>2</sub> <sup>PP2A</sup>, inhibitory subunits of PP2A; catalytic and regulatory subunits of calcineurin: PP2B<sub>A</sub> and PP2B<sub>B</sub>; PP2C; PP5; and PP6. All data were obtained within the linear range of the assay. There was a significant decline in PP2Ac and I<sub>2</sub> <sup>PP2A</sup> expression in older patients, whereas all other parameters remained unchanged with age. It remains to be elucidated whether the decrease in the protein expression of I<sub>2</sub> <sup>PP2A</sup> might elevate cardiac PP2A activity in a detrimental way or is overcome by a reduced protein expression and thus a reduced activity of PP2Ac.</p>","PeriodicalId":53309,"journal":{"name":"Advances in Medicine","volume":"2019 ","pages":"2675972"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2675972","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/2675972","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

Heart failure and aging of the heart show many similarities regarding hemodynamic and biochemical parameters. There is evidence that heart failure in experimental animals and humans is accompanied and possibly exacerbated by increased activity of protein phosphatase (PP) 1 and/or 2A. Here, we wanted to study the age-dependent protein expression of major members of the protein phosphatase family in human hearts. Right atrial samples were obtained during bypass surgery. Patients (n=60) were suffering from chronic coronary artery disease (CCS 2-3; New York Heart Association (NYHA) stage 1-3). Age ranged from 48 to 84 years (median 69). All patients included in the study were given β-adrenoceptor blockers. Other medications included angiotensin-converting enzyme (ACE) or angiotensin-receptor-1 (AT1) inhibitors, statins, nitrates, and acetylsalicylic acid (ASS). 100 µg of right atrial homogenates was used for western blotting. Antibodies against catalytic subunits (and their major regulatory proteins) of all presently known cardiac serine/threonine phosphatases were used for antigen detection. In detail, we studied the expression of the catalytic subunit of PP1 (PP1c); I1 PP1 and I2 PP1, proteins that can inhibit the activity of PP1c; the catalytic subunit of PP2A (PP2Ac); regulatory A-subunit of PP2A (PP2AA); regulatory B56α-subunit of PP2A (PP2AB); I1 PP2A and I2 PP2A, inhibitory subunits of PP2A; catalytic and regulatory subunits of calcineurin: PP2BA and PP2BB; PP2C; PP5; and PP6. All data were obtained within the linear range of the assay. There was a significant decline in PP2Ac and I2 PP2A expression in older patients, whereas all other parameters remained unchanged with age. It remains to be elucidated whether the decrease in the protein expression of I2 PP2A might elevate cardiac PP2A activity in a detrimental way or is overcome by a reduced protein expression and thus a reduced activity of PP2Ac.

Abstract Image

Abstract Image

人心房中丝氨酸/苏氨酸磷酸酶及其抑制剂的年龄依赖性蛋白表达。
心力衰竭和心脏老化在血液动力学和生化参数方面有许多相似之处。有证据表明,实验动物和人类的心力衰竭伴随着蛋白磷酸酶(PP) 1和/或2A活性的增加,并可能加剧。在这里,我们想研究人类心脏中蛋白磷酸酶家族主要成员的年龄依赖性蛋白表达。右心房样本在搭桥手术中获得。患者(n=60)患有慢性冠状动脉疾病(CCS 2-3;纽约心脏协会(NYHA) 1-3期。年龄48 ~ 84岁(中位69岁)。所有纳入研究的患者均给予β-肾上腺素受体阻滞剂。其他药物包括血管紧张素转换酶(ACE)或血管紧张素受体-1 (AT1)抑制剂、他汀类药物、硝酸盐和乙酰水杨酸(ASS)。取右心房匀浆100µg进行免疫印迹。针对目前已知的所有心脏丝氨酸/苏氨酸磷酸酶的催化亚基(及其主要调节蛋白)的抗体用于抗原检测。我们详细研究了PP1催化亚基(PP1c)的表达;I1 PP1和I2 PP1,可以抑制PP1c活性的蛋白;PP2A催化亚基(PP2Ac);PP2A的调控a亚基(PP2AA);PP2A的调控b56 α-亚基(PP2AB);I1 PP2A和I2 PP2A, PP2A的抑制亚基;钙调磷酸酶的催化和调控亚基:PP2BA和PP2BB;PP2C;PP5;和PP6。所有数据均在测定的线性范围内获得。老年患者的PP2Ac和I2 PP2A表达显著下降,而其他参数随年龄保持不变。I2 PP2A蛋白表达的降低是否会以有害的方式提高心脏PP2A的活性,或者通过蛋白表达的降低来克服,从而降低PP2Ac的活性,还有待阐明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
5
审稿时长
22 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信